TEAS RF New Application

XIPERE

Clearside Biomedical, Inc.

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 88221046
Filing Date: 12/07/2018

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88221046
MARK INFORMATION
*MARK \\TICRS\EXPORT17\IMAGEOUT 17\882\210\88221046\xml1\ RFA0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT XIPERE
COLOR MARK NO
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the word XIPERE beginning with a capital "X" followed by the capital letter "I" with an arc-like line beginning at the bottom of the letter I and continuing through the center of the letters P, E, and ending at the bottom of the letter R followed by a capital "E".
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 944 x 250
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Clearside Biomedical, Inc.
*STREET 900 North Point Parkway, Suite 200
*CITY Alpharetta
*STATE
(Required for U.S. applicants)
Georgia
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
30005
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Ocular pharmaceuticals; Ophthalmic preparations
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 010 
*IDENTIFICATION Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; Ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Bassam N. Ibrahim
ATTORNEY DOCKET NUMBER 0080003-115
FIRM NAME Buchanan Ingersoll & Rooney, PC
STREET 1737 King Street, Suite 500
CITY Alexandria
STATE Virginia
COUNTRY United States
ZIP/POSTAL CODE 22314
PHONE 703-836-6620
FAX 703-836-2021
EMAIL ADDRESS bassam.ibrahim@bipc.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY Bryce J. Maynard, Laura K. Pitts, and all other attorneys of the firm
CORRESPONDENCE INFORMATION
NAME Bassam N. Ibrahim
FIRM NAME Buchanan Ingersoll & Rooney, PC
STREET 1737 King Street, Suite 500
CITY Alexandria
STATE Virginia
COUNTRY United States
ZIP/POSTAL CODE 22314
PHONE 703-836-6620
FAX 703-836-2021
*EMAIL ADDRESS bassam.ibrahim@bipc.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 550
*TOTAL FEE PAID 550
SIGNATURE INFORMATION
SIGNATURE NOT PROVIDED
SIGNATORY'S NAME NOT PROVIDED
SIGNATORY'S POSITION NOT PROVIDED
DATE SIGNED NOT PROVIDED



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 88221046
Filing Date: 12/07/2018

To the Commissioner for Trademarks:

MARK: XIPERE (stylized and/or with design, see mark)

The literal element of the mark consists of XIPERE.
The applicant is not claiming color as a feature of the mark. The mark consists of the word XIPERE beginning with a capital "X" followed by the capital letter "I" with an arc-like line beginning at the bottom of the letter I and continuing through the center of the letters P, E, and ending at the bottom of the letter R followed by a capital "E".
The applicant, Clearside Biomedical, Inc., a corporation of Delaware, having an address of
      900 North Point Parkway, Suite 200
      Alpharetta, Georgia 30005
      United States

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Ocular pharmaceuticals; Ophthalmic preparations
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 010:  Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; Ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



The applicant's current Attorney Information:
      Bassam N. Ibrahim and Bryce J. Maynard, Laura K. Pitts, and all other attorneys of the firm of Buchanan Ingersoll & Rooney, PC      1737 King Street, Suite 500
      Alexandria, Virginia 22314
      United States
      703-836-6620(phone)
      703-836-2021(fax)
      bassam.ibrahim@bipc.com (authorized)
The attorney docket/reference number is 0080003-115.

The applicant's current Correspondence Information:
      Bassam N. Ibrahim
      Buchanan Ingersoll & Rooney, PC
      1737 King Street, Suite 500
      Alexandria, Virginia 22314
      703-836-6620(phone)
      703-836-2021(fax)
      bassam.ibrahim@bipc.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: Not Provided    Date: Not Provided
Signatory's Name: Not Provided
Signatory's Position: Not Provided
Payment Sale Number: 88221046
Payment Accounting Date: 12/07/2018

Serial Number: 88221046
Internet Transmission Date: Fri Dec 07 13:05:11 EST 2018
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-201812071305111
10116-88221046-610cfefecf0f3936d64a61c48
ba39e4fbae74f8d748f126d99786725077198135
77-CC-13558-20181207125605057813

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed